Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kobinger GP"'
Autor:
Babuadze GG; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada., Echanove J; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada., Lamarre C; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada., deLaVega MA; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Quebec City, Quebec G1V 0A6, Canada., Fausther-Bovendo H; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada., Racine T; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada; Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac), Canada., M Gomez A; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada., Azizi H; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada., Wade M; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, Quebec G1V 4G2, Canada., Kozak R; Department of Laboratory Medicine and Molecular Diagnostics, Division of Microbiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada., Kobinger GP; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Quebec City, Quebec G1V 0A6, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: gakobing@UTMB.edu.
Publikováno v:
Vaccine [Vaccine] 2021 Dec 03; Vol. 39 (49), pp. 7175-7181. Date of Electronic Publication: 2021 Nov 10.
Autor:
de La Vega MA; Département de microbiologie-infectiologie et immunologie, Université Laval, Quebec, QC G1V 4G2, Canada., Kobinger GP; Département de microbiologie-infectiologie et immunologie, Université Laval, Quebec, QC G1V 4G2, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Electronic address: gary.kobinger@crchudequebec.ulaval.ca.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Apr; Vol. 20 (4), pp. 388-389. Date of Electronic Publication: 2020 Jan 14.
Autor:
Yan J; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Morrow MP; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Chu JS; The Wistar Institute of Anatomy & Biology, 3601 Spruce St, Philadelphia, PA 19104, USA., Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Reed CC; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Khan AS; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Broderick KE; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Kim JJ; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Sardesai NY; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Weiner DB; The Wistar Institute of Anatomy & Biology, 3601 Spruce St, Philadelphia, PA 19104, USA. Electronic address: dweiner@wistar.org.
Publikováno v:
Vaccine [Vaccine] 2018 May 24; Vol. 36 (22), pp. 3079-3089.
Autor:
Pillet S; Medicago Inc., 1020 Route de l'Église, Bureau 600, Québec, QC, Canada; Research Institute of the McGill University Health Center, Montreal, QC, Canada., Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada., Nfon C; National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB, Canada., Di Lenardo TZ; Research Institute of the McGill University Health Center, Montreal, QC, Canada., Babiuk S; National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB, Canada; Department of Immunology, University of Manitoba, MB, Canada., Ward BJ; Medicago Inc., 1020 Route de l'Église, Bureau 600, Québec, QC, Canada., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada; Department of Immunology, University of Manitoba, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Landry N; Medicago Inc., 1020 Route de l'Église, Bureau 600, Québec, QC, Canada. Electronic address: landryn@medicago.com.
Publikováno v:
Vaccine [Vaccine] 2015 Nov 17; Vol. 33 (46), pp. 6282-9. Date of Electronic Publication: 2015 Oct 02.
Autor:
Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada., Fernando L; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada., Fausther-Bovendo H; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada., Alimonti JB; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; Department of Immunology, University of Manitoba, Winnipeg, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada. Electronic address: xiangguo.qiu@phac-aspc.gc.ca.
Publikováno v:
Vaccine [Vaccine] 2014 Sep 29; Vol. 32 (43), pp. 5722-9. Date of Electronic Publication: 2014 Aug 27.
Autor:
Yan J; Inovio Pharmaceuticals, Inc., 1787 Sentry Parkway West, Building 18, Suite 400, Blue Bell, PA 19422, USA., Villarreal DO; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Racine T; Special Pathogens Program, National Microbiology Laboratory, Winnipeg, Manitoba R2E 3R2, Canada., Chu JS; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Walters JN; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Morrow MP; Inovio Pharmaceuticals, Inc., 1787 Sentry Parkway West, Building 18, Suite 400, Blue Bell, PA 19422, USA., Khan AS; Inovio Pharmaceuticals, Inc., 1787 Sentry Parkway West, Building 18, Suite 400, Blue Bell, PA 19422, USA., Sardesai NY; Inovio Pharmaceuticals, Inc., 1787 Sentry Parkway West, Building 18, Suite 400, Blue Bell, PA 19422, USA., Kim JJ; Inovio Pharmaceuticals, Inc., 1787 Sentry Parkway West, Building 18, Suite 400, Blue Bell, PA 19422, USA., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Winnipeg, Manitoba R2E 3R2, Canada., Weiner DB; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: dbweiner@mail.med.upenn.edu.
Publikováno v:
Vaccine [Vaccine] 2014 May 19; Vol. 32 (24), pp. 2833-42. Date of Electronic Publication: 2014 Mar 12.
Autor:
Patel A; National Microbiology Laboratory, Public Health Agency of Canada, Canadian Science Centre for Human and Animal Health, Winnipeg, MB, Canada., Gray M, Li Y, Kobasa D, Yao X, Kobinger GP
Publikováno v:
Vaccine [Vaccine] 2012 Jan 11; Vol. 30 (3), pp. 626-36. Date of Electronic Publication: 2011 Nov 23.
Autor:
Pillet S; INRS-Institut Armand-Frappier, University of Quebec, Laval, Canada., Kobasa D, Meunier I, Gray M, Laddy D, Weiner DB, von Messling V, Kobinger GP
Publikováno v:
Vaccine [Vaccine] 2011 Sep 09; Vol. 29 (39), pp. 6793-801. Date of Electronic Publication: 2011 Jan 04.
Autor:
Patel A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada., Tran K, Gray M, Li Y, Ao Z, Yao X, Kobasa D, Kobinger GP
Publikováno v:
Vaccine [Vaccine] 2009 May 18; Vol. 27 (23), pp. 3083-9. Date of Electronic Publication: 2009 Apr 01.
Autor:
Roy S; Gene Therapy Program, Department of Pathology and Laboratory Medicine, Division of Transfusion Medicine, University of Pennsylvania, Philadelphia, PA 19104-4268, USA., Kobinger GP, Lin J, Figueredo J, Calcedo R, Kobasa D, Wilson JM
Publikováno v:
Vaccine [Vaccine] 2007 Sep 28; Vol. 25 (39-40), pp. 6845-51. Date of Electronic Publication: 2007 Aug 06.